V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210036570 | 210007348 | 1.79 | 74 | Curative (C) | 2014-05-23 | 2014-08-30 | Methotrexate intrathecal | N | N | 210013036 | METHOTREXATE INTRATHECAL |
| 210036571 | 210007353 | null | 115 | Curative (C) | 2015-09-30 | 2015-10-28 | Methotrexate intrathecal | N | N | 210013045 | METHOTREXATE INTRATHECAL |
| 210036572 | 210007358 | null | 42.2 | Curative (C) | 2017-01-13 | 2017-12-29 | Methotrexate intrathecal | Y | N | 210013090 | METHOTREXATE INTRATHECAL |
| 210036573 | 210007368 | null | null | Curative (C) | 2013-07-13 | 2014-07-27 | Methotrexate Intrathecal (any age) | Y | null | 210013093 | METHOTREXATE INTRATHECAL |
| 210036574 | 210018997 | 0 | null | null | 2016-12-03 | 2017-02-13 | Methotrexate intrathecal | Y | null | 210013114 | METHOTREXATE INTRATHECAL |
| 210036575 | 210007385 | 1.62 | 60.5 | Curative (C) | 2014-10-01 | 2014-10-07 | Methotrexate intrathecal | null | N | 210013117 | METHOTREXATE INTRATHECAL |
| 210036576 | 210007392 | null | null | Disease modification (D) | null | 2016-10-21 | Methotrexate intrathecal | N | N | 210013124 | METHOTREXATE INTRATHECAL |
| 210036577 | 210007395 | 1.03 | 15.2 | Curative (C) | 2018-05-12 | 2018-06-09 | Methotrexate intrathecal | Y | N | 210013127 | METHOTREXATE INTRATHECAL |
| 210036578 | 210007404 | 1.76 | null | Curative (C) | 2019-01-19 | 2019-01-26 | Methotrexate intrathecal | N | N | 210013144 | METHOTREXATE INTRATHECAL |
| 210036579 | 210007411 | null | 0 | Curative (C) | 2018-07-21 | 2018-08-04 | Methotrexate intrathecal | Y | N | 210013154 | METHOTREXATE INTRATHECAL |
| 210036580 | 210007415 | 1.7 | 22.4 | Curative (C) | 2013-12-16 | 2014-06-25 | Methotrexate intrathecal | N | N | 210013173 | METHOTREXATE INTRATHECAL |
| 210036581 | 210007425 | 1.79 | 17.5 | Disease modification (D) | 2017-10-20 | 2017-11-10 | Methotrexate intrathecal | N | N | 210013202 | METHOTREXATE INTRATHECAL |
| 210036582 | 210007429 | 1.69 | 14.9 | Curative (C) | 2016-02-05 | 2016-06-03 | Methotrexate intrathecal | 2 | N | 210013223 | METHOTREXATE INTRATHECAL |
| 210036583 | 210007441 | 1.47 | null | Disease modification (D) | 2018-06-28 | 2019-01-25 | Methotrexate intrathecal | Y | null | 210013233 | METHOTREXATE INTRATHECAL |
| 210036584 | 210007453 | 0.83 | 55 | Curative (C) | null | 2018-07-17 | Methotrexate intrathecal | Y | null | 210013256 | METHOTREXATE INTRATHECAL |
| 210036585 | 210007455 | 0.9 | 72.3 | Curative (C) | null | 2019-05-28 | Methotrexate Intrathecal (any age) | Y | null | 210013286 | METHOTREXATE INTRATHECAL |
| 210036586 | 210007462 | null | 56.8 | Curative (C) | 2017-02-01 | 2017-08-15 | Methotrexate intrathecal | N | N | 210013297 | METHOTREXATE INTRATHECAL |
| 210036587 | 210007466 | null | 17.9 | Curative (C) | null | 2015-05-15 | Methotrexate intrathecal | N | N | 210013298 | METHOTREXATE INTRATHECAL |
| 210036589 | 210033133 | 1.87 | 40.6 | null | 2018-06-06 | 2018-06-27 | Methotrexate intrathecal | Y | null | 210013419 | METHOTREXATE INTRATHECAL |
| 210036590 | 210007501 | 0 | 73.1 | Curative (C) | 2017-11-01 | 2018-01-24 | Methotrexate intrathecal | 01 | N | 210013427 | METHOTREXATE INTRATHECAL |
| 210036591 | 210007511 | 1.22 | 58.2 | Curative (C) | 2014-06-10 | 2014-06-10 | Methotrexate intrathecal | N | N | 210013469 | METHOTREXATE INTRATHECAL |
| 210036592 | 210007519 | 1.2 | 18.3 | Adjuvant (A) | null | 2017-03-19 | Methotrexate intrathecal | N | null | 210013478 | METHOTREXATE INTRATHECAL |
| 210036593 | 210007525 | null | 13.6 | null | 2015-11-15 | 2015-11-19 | Methotrexate Intrathecal (any age) | N | N | 210013481 | METHOTREXATE INTRATHECAL |
| 210036594 | 210007534 | 1.82 | 50 | Curative (C) | 2016-05-22 | 2016-05-22 | Methotrexate Intrathecal (any age) | null | N | 210013536 | METHOTREXATE INTRATHECAL |
| 210036595 | 210019049 | null | 28.7 | Curative (C) | null | 2017-03-04 | Methotrexate Intrathecal (any age) | Y | N | 210013538 | METHOTREXATE INTRATHECAL |
| 210036596 | 210007544 | 0 | 27.5 | Disease modification (D) | 2018-05-25 | 2018-05-30 | Methotrexate intrathecal | 02 | N | 210013548 | METHOTREXATE INTRATHECAL |
| 210036597 | 210007549 | 1.73 | 60.7 | Curative (C) | 2014-07-28 | 2014-07-28 | Methotrexate intrathecal | N | N | 210013562 | METHOTREXATE INTRATHECAL |
| 210036600 | 210007567 | 1.72 | 17.4 | Curative (C) | null | 2018-02-08 | Methotrexate intrathecal | 02 | N | 210013589 | METHOTREXATE INTRATHECAL |
| 210036602 | 210007586 | 1.75 | 88.75 | Curative (C) | 2015-10-16 | 2015-11-27 | UKALL14- Ph 2 Induction | N | N | 210013639 | UKALL2014 |
| 210036603 | 210007590 | 1.83 | 66.2 | Curative (C) | 2018-03-14 | 2019-02-06 | UKALL14- Intens/CNS Proph | Y | N | 210013640 | UKALL2014 |
| 210036604 | 210007600 | 1.75 | 103 | Disease modification (D) | 2014-12-23 | 2015-11-27 | UKALL14- Ph 2 Induction | 02 | N | 210013643 | UKALL2014 |
| 210036605 | 210007610 | 1.79 | 78.6 | Curative (C) | 2013-12-03 | 2014-02-13 | UKALL14- Ph 2 Induction | null | null | 210013655 | UKALL2014 |
| 210036606 | 210007617 | 1.75 | 89.7 | null | 2016-12-25 | 2017-01-03 | UKALL14- Maintenance + Imatinib | N | null | 210013660 | UKALL2014 |
| 210036607 | 210019085 | 1.83 | 83.4 | null | null | 2018-08-10 | UKALL14- Intens/CNS Proph | Y | N | 210013724 | UKALL2014 |
| 210036608 | 210007647 | 1.74 | 87.4 | Curative (C) | 2016-11-30 | 2016-12-03 | UKALL14- Maintenance | Y | N | 210013727 | UKALL2014 |
| 210036609 | 210007652 | 1.75 | 72.6 | Curative (C) | 2013-05-21 | 2013-09-19 | UKALL 14 TRIAL | null | null | 210013740 | UKALL2014 |
| 210036610 | 210007657 | 1.82 | 71.3 | Disease modification (D) | 2018-03-12 | 2018-06-10 | UKALL14- Maintenance | Y | N | 210013754 | UKALL2014 |
| 210036611 | 210007667 | 1.82 | null | Curative (C) | 2014-01-17 | 2014-01-28 | UKALL14- Maintenance | Y | null | 210013789 | UKALL2014 |
| 210036612 | 210007685 | 1.45 | 62 | Curative (C) | 2019-04-05 | 2019-04-18 | UKALL14- Intens/CNS Proph +Imatinib | Y | N | 210013840 | UKALL2014 |
| 210036613 | 210007691 | 1.6 | 80.8 | Adjuvant (A) | 2016-01-27 | 2017-10-17 | UKALL14- Ph 2 Induction | 01 | N | 210013846 | UKALL2014 |
| 210036614 | 210007702 | null | 71.7 | Curative (C) | 2017-11-22 | 2017-11-22 | UKALL14- Cons Cycle 1 | N | null | 210013874 | UKALL2014 |
| 210036615 | 210007710 | 1.83 | 68 | Curative (C) | 2015-10-06 | 2016-07-21 | UKALL 14 TRIAL | Y | null | 210013876 | UKALL2014 |
| 210036616 | 210007717 | 1.66 | 76 | Curative (C) | 2016-06-23 | 2016-06-28 | UKALL14- Cons Cycle 2 | 02 | N | 210013886 | UKALL2014 |
| 210036617 | 210007720 | 1.68 | 50.7 | Curative (C) | 2016-05-24 | 2016-05-24 | UKALL14- Ph 2 Induction | Y | N | 210013889 | UKALL2014 |
| 210036618 | 210007726 | 1.82 | 75.2 | Curative (C) | 2014-05-14 | 2014-07-18 | UKALL14- Maintenance | Y | null | 210013914 | UKALL2014 |
| 210036619 | 210007735 | 1.94 | 95.4 | Disease modification (D) | 2016-01-31 | 2016-02-03 | UKALL14- Ph 2 Induction | Y | null | 210013926 | UKALL2014 |
| 210036620 | 210007741 | 1.7 | 91.2 | Curative (C) | 2015-07-24 | 2015-07-24 | UKALL14- Cons Cycle 1 | Y | N | 210013932 | UKALL2014 |
| 210036621 | 210007747 | 1.88 | 89.8 | Curative (C) | 2016-01-05 | 2016-01-18 | UKALL14- Intens/CNS Proph | Y | N | 210013944 | UKALL2014 |
| 210036623 | 210007763 | 1.58 | 57.2 | Adjuvant (A) | 2016-02-02 | 2016-07-17 | UKALL14- Maintenance | null | null | 210013990 | UKALL2014 |
| 210036624 | 210019134 | 1.76 | 94.3 | Curative (C) | 2017-02-03 | 2018-02-22 | UKALL14- Cons Cycle 2 | Y | null | 210014003 | UKALL2014 |